<unk>  is a human granulocyte colony-stimulating factor that is FDA approved for the treatment of cancer patients receiving myelosuppressive chemotherapy， patients with acute myeloid leukemiareceiving induction or consolidation chemotherapy， cancer patients receiving bone marrow transplant， patients undergoing peripheral blood progenitor cell collection and therapy， patients with severe chronic neutropenia.   Common adverse reactions include bone pain.
Filgrastim
Tbo-filgrastim
Pegfilgrastim
Romiplostim
Interferon
Granulocyte colony stimulating factor
Interferon Alfa-n3
Trimetrexate